Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 1b, Open-Label, Safety, Tolerability, and Efficacy Study of HC-7366 in Combination with Belzutifan (WELIREG) in Patients with Locally Advanced (Inoperable) or Metastatic Renal Cell Carcinoma
Active
$625.4K Funding
7 People
External
Related Topics
oncology,
clinical trial,
drug combination,
efficacy,
patient safety
People
Thomas Schlabach
(CD)
Cancer Center Division
﹒Clinical Research Coordinator II
Edward Gelmann
Principal Investigator (PI)
Medicine
﹒Professor
Jaron Solsky
(CD)
Cancer Center Division
﹒Clinical Research Manager I
Bryan Clines
(CD)
Cancer Center Division
﹒Research Compliance Administrator III
Cyndie Neal
(CD)
Cancer Center Division
﹒Clinical Research Coordinator II
Brianna Denton
(CD)
Cancer Center Division
﹒Research Compliance Manager I
Patricia Robles Quihuis
(CD)
Cancer Center Division
﹒Research Nurse III
